Anti-h PSA 8311 SPRN-1

Datasheet

Catalog Number: 100103

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Key Features

Form :

Liquid, may turn slightly opaque during storage

Species Reactivity :

Human

Application :

FIA

SKU Price(USD) Size Qty

100103_1 mg $400.00 1 mg

Qty:

+ -

Custom Quote

Bulk or bespoke? We IVDo that
Request a call back
to discuss your information requirements

Key Documents

Product Specification

Product Overview

Product Name	Anti-h PSA 8311 SPRN-1
Catalog Number	100103
Description	Monoclonal mouse antibody, cultured in vitro under conditions free from animal-derived components.
Application	FIA

Further Specification

Form/Appearance	Liquid, may turn slightly opaque during storage
Concentration	1.0–1.1 mg/ml
Notes	Clone 8311 reacts with non-reduced and reduced intact PSA but not with reduced PSA fragments (Rye et al., 1999). In the same study affinities for free-PSA and PSA-ACT-complex were, 1.7 x 10-10 mol/l and 1.55 x 10-10, respectively. They also noted that antibodies binding to epitope group 6 form a good pair with antibodies from groups 1 and 3. Clone 8311 crossreacts with human kallikrein-2 (Black, 1999b) and can be used to develop a hK2-assay.
Isotype	IgG2a
Clonality	Monoclonal
Epitope	Residues 3–11, group 6a as described in Rye et al. (1999)
Purity	≥ 95 %
Affinity constant	KA= 1 x 10¹⁰ 1/M
Associated Products	Native PSA antigen, Lee Biosolutions 497-11 and 497-17
Buffer	37 mM citrate, 125 mM phosphate, pH 6.0, 0.9 % NaCI, 0.095 % NaN3 as a preservative
IEF Profile	6.8–7.5
Cross Reactivity	PSA/α1-ACT complex 76 %, Kallikrein < 0.36 %, PAP < 0.36 %
Specificity	Antibody recognizes human prostate-specific antigen

Storage and Shipping

Storage	+2-8°C
Shipping	Cold packs
Shelf Life	36 months

References

References	Black, M.H., Grass, C.L., Leinonen, J., Stenman, U-H. and Diamandis, E.P., (1999a) Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays. Clin. Chem., 45(3):347-354 Black, M.H., Magklara, A., Obiezu, C.V., Melegos, D.N. and Diamandis, E.P., (1999b) Development of an ultrasensitive immuoassay for human glandular kallikrein with no crossreactivity from prostate-specific antigen. Clin. Chem., 45(6):790-799 Ferguson, R.A., Yu, H., Kalyvas, M., Zammit, S. and Diamandis, E.P., (1996) Ultrasensitive detection of prostate-specific antigen by time-resolved immunofluorometric assay and the Immulite® immunochemiluminescent third-generation assay: potential applications in prostate and breast cancer. Clin. Chem., 42(5):675-684 Magklara, A., Scorilas, A., López-Otín, C., Vizoso, F., Ruibal, A. and Diamandis, E.P., (1999) Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid. Clin. Chem., 45(10):1774-1780 Obiezu, C.V., Giltay, E.J., Magklara, A., Scorilas, A., Gooren, L.J.G., Yu, H., Howarth, D.J.C. and Diamandis, E.P., (2000) Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals. Clin. Chem., 46(6):859-862 Rye, P.D., Bormer, O.P. and Paus, E. (guest editors) (1999), ISOBM TD-3 International Workshop on monoclonal antibodies against prostate-specific antigen. Tumor Biol., 20(suppl 1):1-94

Black, M.H., Grass, C.L., Leinonen, J., Stenman, U-H. and Diamandis, E.P., (1999a) Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays. Clin. Chem., 45(3):347-354 Black, M.H., Magklara, A., Obiezu, C.V., Melegos, D.N. and Diamandis, E.P., (1999b) Development of an ultrasensitive immuoassay for human glandular kallikrein with no crossreactivity from prostate-specific antigen. Clin. Chem., 45(6):790-799 Ferguson, R.A., Yu, H., Kalyvas, M., Zammit, S. and Diamandis, E.P., (1996) Ultrasensitive detection of prostate-specific antigen by time-resolved immunofluorometric assay and the Immulite® immunochemiluminescent third-generation assay: potential applications in prostate and breast cancer. Clin. Chem., 42(5):675-684 Magklara, A., Scorilas, A., López-Otín, C., Vizoso, F., Ruibal, A. and Diamandis, E.P., (1999) Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid. Clin. Chem., 45(10):1774-1780 Obiezu, C.V., Giltay, E.J., Magklara, A., Scorilas, A., Gooren, L.J.G., Yu, H., Howarth, D.J.C. and Diamandis, E.P., (2000) Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals. Clin. Chem., 46(6):859-862 Rye, P.D., Bormer, O.P. and Paus, E. (guest editors) (1999), ISOBM TD-3 International Workshop on monoclonal antibodies against prostate-specific antigen. Tumor Biol., 20(suppl 1):1-94